235 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (89)
- Autoimmune Disorders (1)
- Blood Disorders (3)
- Bone & Muscle (1)
- Cancer (18)
- COVID-19 (Coronavirus) (4)
- Diabetes (2)
- Endocrine & Metabolic Disease (3)
- Hair and Skin Disorders (1)
- Healthy Volunteers (12)
- Heart Disease (17)
- Kidney Disease (1)
- Liver Disease (2)
- Lung Disease (2)
- Neurological Disorders (3)
- Nutrition (2)
- Obesity (2)
- Obstetrics & Gynecology (3)
- Pediatrics (7)
- Surgery (2)
- Transplant (3)
Displaying 1 - 3 of 3
Condition: Obstetrics & Gynecology / Contraception
Investigator: Carolyn Westhoff, MD
Status: Closed
The unintended pregnancy rate is rising despite increased availability and use of different types of emergency contraception (EC) pills. Few studies have addressed reasons for EC failure, yet such an investigation may allow researchers to better understand if EC can be used more successfully.Recently studies have shown that EC failure rates are…
Condition: Cancer / Gynecologic Cancer
Investigator: June Hou, MD
Status: Closed
The purpose of this research study is to test the safety and determine the highest tolerable dose of SL-172154 (study drug) that can be given with Pegylated Liposomal Doxorubicin (PLD) or Mirvetuximab Soravtansine (MIRV). Another purpose of this study is to understand if SL-127154 and PLD or MIRV is effective in managing…
Condition: Cancer / Gynecologic Cancer
Investigator: Jason Wright, MD
Status: Closed
XMT-1536 (upifitamab rilsodotin) is a targeted therapy, which means that it is directed specifically at a tumor. It is a type of antibody-drug conjugate; this means it has 2 parts that are joined together into one drug. The first part is an antibody that binds to NaPi2b (sodium-dependent phosphate transporter), a protein on the surface of the cells of your…